# Ezisurg Medical Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ezisurg-medical-co

- Industry: Medical Devices & Equipment
- Headquarters: Shanghai, China
- Website: www.ezisurg.com
- Total disclosed funding: $21M
- Latest round: Series C (Aug 31, 2020)
- Investors on record: 4

## About

Established in 2011 and based in Shanghai, China, Ezisurg Medical Co., Ltd. is a medical technology company that provides minimally invasive products. The subsidiaries have been set up in the United States and the Netherlands. The company has acquired 55 global certifications including 7 FDA approvals and 14 CE marks. In August 2020, it closed a series C funding. In 2022, the disposable cyst pelvic endoscopy system acquired NMPA registration.

The company is committed to providing minimally invasive surgical medical devices for tumors. The products can be categorized into luminal anastomosis series, ultrasonic knife products, and optical imaging products, which have been used in more than 1,000 hospitals across China, of which Grade 3A hospitals account for more than 40%.

## Funding rounds

- Series C, Aug 31, 2020 — Xiamen C&D Group, GL Ventures
- Series B, May 29, 2020, $21M — Shanghai Pudong Hi-tech Investment, Xiamen C&D Group, BioTrack Capital

## Investors

- Shanghai Pudong Hi-tech Investment (https://capitalatlas.ai/funds/shanghai-pudong-hi-tech-investment) — Series B
- Xiamen C&D Group — Series B, Series C
- BioTrack Capital (https://capitalatlas.ai/funds/biotrack-capital) — Series B
- GL Ventures (https://capitalatlas.ai/funds/gl-ventures) — Series C